Virtual Reality Social Cognition Training for Adults With Autism Spectrum Disorders
NCT ID: NCT02139514
Last Updated: 2016-10-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2013-01-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All the recruitment will be taking place at Yale Child Study Center (YCSC), while the intervention will be delivered online by therapists located at the Center for BrainHealth at the University of Texas at Dallas (UTD). The intervention is called Virtual Reality-Social Cognition Training (VR-SCT) and has been approved by the IRB at UTD (approval number #06-54).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Virtual Reality Social Cognition Training
Virtual Reality Social Cognition Training
Virtual Reality Social Cognition Training
Social skills training via virtual reality with trained therapist.
Control
Participants in the Control condition will be offered treatment following the Control condition.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Virtual Reality Social Cognition Training
Social skills training via virtual reality with trained therapist.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Age: 18-40, inclusive
2. A male or female outpatient
2. High-functioning (so that the treatment can effectively benefit the subjects):
1. Full Scale Intelligence Quotient (IQ) of WASI at least 80
2. Able to give informed consent prior to initiation of any protocol required procedures
3. Autism Spectrum Disorder:
1. Having a current primary diagnosis of Autism Spectrum Disorder (including Asperger's Disorder) from a licensed psychologist/psychiatrist or from a school diagnostician, as defined by the DSM-IV criteria.
2. For this project, diagnosis will not be determined by our assessment. The participants we enroll will already carry a current primary diagnosis of Autism Spectrum Disorder. This verification of their diagnosis may also come from study personnel who have seen and/or treated the patient prior to his or her involvement in the project and can verbally confirm that they carry the proper diagnosis.
4. Mean Length of Utterance (MLU) must be at least 4-5 words (the intervention method requires this)
Exclusion Criteria
1. Those who are not fluent in written and oral English will not be eligible to participate, as many of the instruments are not validated in other languages.
2. Significant hearing loss or other severe sensory impairment
3. Inability to read self-report instruments
2. Health criteria:
1. Those whose clinical status (e.g., serious suicidal or homicidal risk) requires inpatient or day hospital treatment
2. Those with a history of seizures, or current use of anticonvulsants
3. A fragile health status
4. A history of significant head trauma or serious brain or psychiatric illness
5. Having any other current psychiatric condition or complications, such as
i. Diagnosed with substance dependence within the last three months. ii. Current use of prescription medications that may affect cognitive processes under study.
iii. Current primary diagnosis of bipolar disorder I or II iv. Axis I psychopathology v. Depression
3. Any metal or electromagnetic implants, including:
1. Cardiac pacemaker
2. Defibrillator
3. Artificial heart valve
4. Aneurysm clip
5. Cochlear implants
6. Shrapnel
7. Neurostimulators
8. History of metal fragments in eyes or skin
18 Years
40 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Texas
OTHER
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yale University
New Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1211011083
Identifier Type: -
Identifier Source: org_study_id